Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health Limited has notified the market that 2,316,848 performance rights have lapsed after the conditions attached to those rights were not met or became incapable of being satisfied, effective 28 January 2026. The cessation of these securities reduces the company’s pool of potential future equity dilution, providing greater clarity for existing shareholders regarding the current capital structure, although it may also signal that certain performance or strategic milestones underpinning these rights were not achieved.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an Australian-listed company on the ASX (code: VIT) operating in the health sector. The filing relates to its issued capital structure, specifically performance rights previously granted under its equity arrangements.
Average Trading Volume: 257,024
Technical Sentiment Signal: Sell
Current Market Cap: A$37.78M
See more data about VIT stock on TipRanks’ Stock Analysis page.